Clinical Trials Insight: 700035336
Phase of Trial: Phase I
Latest Information Update: 07 Jan 2009
At a glance
- Drugs IQP 0410 (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors ImQuest Life Sciences
- 07 Jan 2009 An IND application has been submitted to the US FDA, as reported by ImQuest Life Sciences. The trial is expected to begin in Q1 2009.
- 16 Jul 2008 New trial record.
- 09 Jul 2008 ImQuest Life Sciences plans to submit an Investigational New Drug application for IQP 0410 in the third quarter of 2008.